PhRMA last week released new guidelines for improving racial and ethnic diversity in clinical trials.

In its guidelines, PhRMA outlined four principles to address systemic racism and reduce health disparities in clinical research. They include working with advocacy groups; adopting enrollment and retention practices that make participation less burdensome; using real-world data even after products have been approved; and encouraging sponsors to clearly detail their diversity inclusion policies on their websites.

To read the PhRMA guidelines, click here: https://onphr.ma/3kOGiVw.